Jan 2022 $2 M No. 5 Under $2 million 3
Reset Therapeutics, Inc.: Raise no. 5, Jan 2022 × Investors in this round 3 investors had bought by the notice of Jan 25, 2022: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Glenn B Batchelder · Executive Officer, Director Shu B Kurosaki · Executive Officer Blair B Jackson · Director Frederick B Craves · Director Steve B Kay · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Shu Kurosaki, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 25, 2022. Read the notice at the SEC .
debt, options SEC Sep 2019 $6 M No. 4 $2 to $10 million 3
Reset Therapeutics, Inc.: Raise no. 4, Sep 2019 × Investors in this round 3 investors had bought by the notice of Oct 24, 2019: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Glenn B Batchelder · Executive Officer, Director Shuichi B Kurosaki · Executive Officer Blair B Jackson · Director Frederick B Craves · Director Steve B Kay · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Shuichi Kurosaki, Treasurer. Source: SEC Form D, newest notice filed Oct 24, 2019. Read the notice at the SEC .
debt, options SEC Jun 2018 $2 M No. 3 Under $2 million 3
Reset Therapeutics, Inc.: Raise no. 3, Jun 2018 × Investors in this round 3 investors had bought by the notice of Jun 20, 2018: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Shuichi B Kurosaki · Executive Officer Blair B Jackson · Director Frederick B Craves · Director Glenn B Batchelder · Director Steve B Kay · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Shuichi Kurosaki, Treasurer. Source: SEC Form D, newest notice filed Jun 20, 2018. Read the notice at the SEC .
debt, options SEC Feb 2016 $30 M No. 2 $10 to $50 million 2
Reset Therapeutics, Inc.: Raise no. 2, Feb 2016 × Investors in this round 2 investors had bought by the notice of Feb 19, 2016: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $30 M of $47 M offered; $17 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Paul B Humphries · Executive Officer Ross Bersot · Executive Officer, Director Shuichi B Kurosaki · Executive Officer Frederick B Craves · Director Hoyoung B Huh · Director Peter B Schultz · Director Steve B Kay · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Shuichi Kurosaki, Treasurer. Source: SEC Form D, newest notice filed Feb 19, 2016. Read the notice at the SEC .
equity SEC Nov 2013 $15 M No. 1 $10 to $50 million 2
Reset Therapeutics, Inc.: Raise no. 1, Nov 2013 × Investors in this round 2 investors had bought by the notice of Dec 3, 2013: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $16 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Paul B Humphries · Executive Officer Ross Bersot · Executive Officer, Director Shuichi B Kurosaki · Executive Officer Frederick B Craves · Director Peter B Schultz · Director Steve B Kay · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ross Bersot, President. Source: SEC Form D, newest notice filed Dec 3, 2013. Read the notice at the SEC .
equity SEC